{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:39:53Z","timestamp":1753893593541,"version":"3.41.2"},"reference-count":84,"publisher":"Sociedade Brasileira de Cardiologia","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,7]]},"DOI":"10.36660\/abc.20220496","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T13:26:54Z","timestamp":1702042014000},"source":"Crossref","is-referenced-by-count":1,"title":["Estrat\u00e9gias Percut\u00e2neas em Doen\u00e7as Estruturais: Foco em Insufici\u00eancia Card\u00edaca Cr\u00f4nica"],"prefix":"10.36660","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6055-6682","authenticated-orcid":false,"given":"Filippe Barcellos","family":"Filippini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1273-1823","authenticated-orcid":false,"given":"Henrique Barbosa","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edimar","family":"Bocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Bacal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2533-5638","authenticated-orcid":false,"given":"Fabiana G.","family":"Marcondes-Braga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3712-1175","authenticated-orcid":false,"given":"Monica S.","family":"Avila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine Daiana","family":"Sturmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5030-6727","authenticated-orcid":false,"given":"Mauricio Felippi de S\u00e1","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Kanhouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5936-8622","authenticated-orcid":false,"given":"Ant\u00f4nio Fernando","family":"Freire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Cassar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre A.","family":"Abizaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6260-9626","authenticated-orcid":false,"suffix":"Jr","given":"F\u00e1bio S\u00e2ndoli de","family":"Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22636","reference":[{"issue":"10","key":"key20231208082649_B1","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart Disease and Stroke Statistics-2019 Update: a Report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","unstructured":"1. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics-2019 Update: a Report from the American Heart Association. Circulation. 2019;139(10):e56-e528. doi: 10.1161\/CIR.0000000000000659.","journal-title":"Circulation"},{"issue":"3","key":"key20231208082649_B2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the Impact of Heart Failure in the United States: a Policy Statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","unstructured":"2. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the Impact of Heart Failure in the United States: a Policy Statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606-19. doi: 10.1161\/HHF.0b013e318291329a.","journal-title":"Circ Heart Fail"},{"issue":"1","key":"key20231208082649_B3","first-page":"41","article-title":"Spatial Distribution of Mortality for Heart Failure in Brazil, 1996 - 2017","volume":"118","author":"Cestari","year":"2022","unstructured":"3. Cestari VRF, Garces TS, Sousa GJB, Maranh\u00e3o TA, Souza Neto JD, Pereira MLD, et al. Spatial Distribution of Mortality for Heart Failure in Brazil, 1996 - 2017. Arq Bras Cardiol. 2022;118(1):41-51. doi: 10.36660\/abc.20201325.","journal-title":"Arq Bras Cardiol"},{"issue":"7","key":"key20231208082649_B4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.001943","article-title":"Transcatheter Structural Heart Interventions for the Treatment of Chronic Heart Failure","volume":"8","author":"Del Trigo","year":"2015","unstructured":"4. Del Trigo M, Rod\u00e9s-Cabau J. Transcatheter Structural Heart Interventions for the Treatment of Chronic Heart Failure. Circ Cardiovasc Interv. 2015;8(7):e001943. doi: 10.1161\/CIRCINTERVENTIONS.114.001943.","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"key20231208082649_B5","first-page":"1174","article-title":"Emerging Topics Update of the Brazilian Heart Failure Guideline - 2021","volume":"116","author":"Marcondes-Braga","year":"2021","unstructured":"5. Marcondes-Braga FGM, Moura LAZ, Issa VS, Vieira JL, Rohde LE, Sim\u00f5es MV, et al. Emerging Topics Update of the Brazilian Heart Failure Guideline - 2021. Arq Bras Cardiol. 2021;116(6):1174-212. doi: 10.36660\/abc.20210367.","journal-title":"Arq Bras Cardiol"},{"issue":"6","key":"key20231208082649_B6","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s10741-018-9687-y","article-title":"Implantable Devices for Heart Failure Monitoring and Therapy","volume":"23","author":"Afari","year":"2018","unstructured":"6. Afari ME, Syed W, Tsao L. Implantable Devices for Heart Failure Monitoring and Therapy. Heart Fail Rev. 2018;23(6):935-44. doi: 10.1007\/s10741-018-9687-y.","journal-title":"Heart Fail Rev"},{"issue":"3","key":"key20231208082649_B7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCHEARTFAILURE.109.867549","article-title":"Continuous Monitoring of Intrathoracic Impedance and Right Ventricular Pressures in Patients with Heart Failure","volume":"3","author":"Vanderheyden","year":"2010","unstructured":"7. Vanderheyden M, Houben R, Verstreken S, St\u00e5hlberg M, Reiters P, Kessels R, et al. Continuous Monitoring of Intrathoracic Impedance and Right Ventricular Pressures in Patients with Heart Failure. Circ Heart Fail. 2010;3(3):370-7. doi: 10.1161\/CIRCHEARTFAILURE.109.867549.","journal-title":"Circ Heart Fail"},{"issue":"11","key":"key20231208082649_B8","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jacc.2007.10.061","article-title":"Randomized Controlled Trial of an Implantable Continuous Hemodynamic Monitor in Patients with Advanced Heart Failure: the COMPASS-HF Study","volume":"51","author":"Bourge","year":"2008","unstructured":"8. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, et al. Randomized Controlled Trial of an Implantable Continuous Hemodynamic Monitor in Patients with Advanced Heart Failure: the COMPASS-HF Study. J Am Coll Cardiol. 2008;51(11):1073-9. doi: 10.1016\/j.jacc.2007.10.061.","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"key20231208082649_B9","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1161\/CIRCULATIONAHA.111.043042","article-title":"Intrathoracic Impedance Monitoring, Audible Patient Alerts, and Outcome in Patients with Heart Failure","volume":"124","author":"van Veldhuisen","year":"2011","unstructured":"9. van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie MR, Jondeau G, et al. Intrathoracic Impedance Monitoring, Audible Patient Alerts, and Outcome in Patients with Heart Failure. Circulation. 2011;124(16):1719-26. doi: 10.1161\/CIRCULATIONAHA.111.043042.","journal-title":"Circulation"},{"issue":"1","key":"key20231208082649_B10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.healun.2006.10.006","article-title":"A Wireless Pressure Sensor for Monitoring Pulmonary Artery Pressure in Advanced Heart Failure: Initial Experience","volume":"26","author":"Castro","year":"2007","unstructured":"10. Castro PF, Concepci\u00f3n R, Bourge RC, Mart\u00ednez A, Alcaino M, Deck C, et al. A Wireless Pressure Sensor for Monitoring Pulmonary Artery Pressure in Advanced Heart Failure: Initial Experience. J Heart Lung Transplant. 2007;26(1):85-8. doi: 10.1016\/j.healun.2006.10.006.","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"key20231208082649_B11","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ahj.2010.10.041","article-title":"Safety and Accuracy of a Wireless Pulmonary Artery Pressure Monitoring System in Patients with Heart Failure","volume":"161","author":"Abraham","year":"2011","unstructured":"11. Abraham WT, Adamson PB, Hasan A, Bourge RC, Pamboukian SV, Aaron MF, et al. Safety and Accuracy of a Wireless Pulmonary Artery Pressure Monitoring System in Patients with Heart Failure. Am Heart J. 2011;161(3):558-66. doi: 10.1016\/j.ahj.2010.10.041.","journal-title":"Am Heart J"},{"issue":"9766","key":"key20231208082649_B12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless Pulmonary Artery Haemodynamic Monitoring in Chronic Heart Failure: a Randomised Controlled Trial","volume":"377","author":"Abraham","year":"2011","unstructured":"12. Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, et al. Wireless Pulmonary Artery Haemodynamic Monitoring in Chronic Heart Failure: a Randomised Controlled Trial. Lancet. 2011;377(9766):658-66. doi: 10.1016\/S0140-6736(11)60101-3.","journal-title":"Lancet"},{"issue":"15","key":"key20231208082649_B13","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.jacc.2017.08.010","article-title":"Pulmonary Artery Pressure-Guided Management of Patients with Heart Failure and Reduced Ejection Fraction","volume":"70","author":"Givertz","year":"2017","unstructured":"13. Givertz MM, Stevenson LW, Costanzo MR, Bourge RC, Bauman JG, Ginn G, et al. Pulmonary Artery Pressure-Guided Management of Patients with Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol. 2017;70(15):1875-86. doi: 10.1016\/j.jacc.2017.08.010.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"key20231208082649_B14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/CIRCHEARTFAILURE.113.001229","article-title":"Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure with Preserved Ejection Fraction","volume":"7","author":"Adamson","year":"2014","unstructured":"14. Adamson PB, Abraham WT, Bourge RC, Costanzo MR, Hasan A, Yadav C, et al. Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure with Preserved Ejection Fraction. Circ Heart Fail. 2014;7(6):935-44. doi: 10.1161\/CIRCHEARTFAILURE.113.001229.","journal-title":"Circ Heart Fail"},{"issue":"10304","key":"key20231208082649_B15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(21)01754-2","article-title":"Haemodynamic-Guided Management of Heart Failure (GUIDE-HF): a Randomised Controlled Trial","volume":"398","author":"Lindenfeld","year":"2021","unstructured":"15. Lindenfeld J, Zile MR, Desai AS, Bhatt K, Ducharme A, Horstmanshof D, et al. Haemodynamic-Guided Management of Heart Failure (GUIDE-HF): a Randomised Controlled Trial. Lancet. 2021;398(10304):991-1001. doi: 10.1016\/S0140-6736(21)01754-2.","journal-title":"Lancet"},{"issue":"8","key":"key20231208082649_B16","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006863","article-title":"Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes from the CardioMEMS Post-Approval Study","volume":"13","author":"Shavelle","year":"2020","unstructured":"16. Shavelle DM, Desai AS, Abraham WT, Bourge RC, Raval N, Rathman LD, et al. Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes from the CardioMEMS Post-Approval Study. Circ Heart Fail. 2020;13(8):e006863. doi: 10.1161\/CIRCHEARTFAILURE.119.006863.","journal-title":"Circ Heart Fail"},{"issue":"7","key":"key20231208082649_B17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/clc.22696","article-title":"Cost-Effectiveness of Remote Cardiac Monitoring with the CardioMEMS Heart Failure System","volume":"40","author":"Schmier","year":"2017","unstructured":"17. Schmier JK, Ong KL, Fonarow GC. Cost-Effectiveness of Remote Cardiac Monitoring with the CardioMEMS Heart Failure System. Clin Cardiol. 2017;40(7):430-6. doi: 10.1002\/clc.22696.","journal-title":"Clin Cardiol"},{"issue":"1","key":"key20231208082649_B18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ehf2.13748","article-title":"Real-World Evidence in a National Health Service: Results of the UK CardioMEMS HF System Post-Market Study","volume":"9","author":"Cowie","year":"2022","unstructured":"18. Cowie MR, Flett A, Cowburn P, Foley P, Chandrasekaran B, Loke I, et al. Real-World Evidence in a National Health Service: Results of the UK CardioMEMS HF System Post-Market Study. ESC Heart Fail. 2022;9(1):48-56. doi: 10.1002\/ehf2.13748.","journal-title":"ESC Heart Fail"},{"issue":"36","key":"key20231208082649_B19","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure","volume":"42","author":"McDonagh","year":"2021","unstructured":"19. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Eur Heart J. 2021;42(36):3599-726. doi: 10.1093\/eurheartj\/ehab368.","journal-title":"Eur Heart J"},{"issue":"10394","key":"key20231208082649_B20","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(23)00923-6","article-title":"Remote Haemodynamic Monitoring of Pulmonary Artery Pressures in Patients with Chronic Heart Failure (MONITOR-HF): a Randomised Clinical Trial","volume":"401","author":"Brugts","year":"2023","unstructured":"20. Brugts JJ, Radhoe SP, Clephas PRD, Aydin D, van Gent MWF, Szymanski MK, et al. Remote Haemodynamic Monitoring of Pulmonary Artery Pressures in Patients with Chronic Heart Failure (MONITOR-HF): a Randomised Clinical Trial. Lancet. 2023;401(10394):2113-23. doi: 10.1016\/S0140-6736(23)00923-6.","journal-title":"Lancet"},{"issue":"25","key":"key20231208082649_B21","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1161\/CIRCULATIONAHA.107.702191","article-title":"Direct Left Atrial Pressure Monitoring in Ambulatory Heart Failure Patients: Initial Experience with a New Permanent Implantable Device","volume":"116","author":"Ritzema","year":"2007","unstructured":"21. Ritzema J, Melton IC, Richards AM, Crozier IG, Frampton C, Doughty RN, et al. Direct Left Atrial Pressure Monitoring in Ambulatory Heart Failure Patients: Initial Experience with a New Permanent Implantable Device. Circulation. 2007;116(25):2952-9. doi: 10.1161\/CIRCULATIONAHA.107.702191.","journal-title":"Circulation"},{"issue":"9","key":"key20231208082649_B22","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1161\/CIRCULATIONAHA.108.800490","article-title":"Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure","volume":"121","author":"Ritzema","year":"2010","unstructured":"22. Ritzema J, Troughton R, Melton I, Crozier I, Doughty R, Krum H, et al. Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure. Circulation. 2010;121(9):1086-95. doi: 10.1161\/CIRCULATIONAHA.108.800490.","journal-title":"Circulation"},{"issue":"6","key":"key20231208082649_B23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.cardfail.2015.04.012","article-title":"Rationale and Design of the Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study (LAPTOP-HF)","volume":"21","author":"Maurer","year":"2015","unstructured":"23. Maurer MS, Adamson PB, Costanzo MR, Eigler N, Gilbert J, Gold MR, et al. Rationale and Design of the Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study (LAPTOP-HF). J Card Fail. 2015;21(6):479-88. doi: 10.1016\/j.cardfail.2015.04.012.","journal-title":"J Card Fail"},{"issue":"6","key":"key20231208082649_B24","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1002\/ehf2.13033","article-title":"A Rise in Left Atrial Pressure Detected by the V-LAP\u2122 System for Patients with Heart Failure During the Coronavirus Disease 2019 Pandemic","volume":"7","author":"Perl","year":"2020","unstructured":"24. Perl L, Avraham BB, Vaknin-Assa H, Gal TB, Kornowski R. A Rise in Left Atrial Pressure Detected by the V-LAP\u2122 System for Patients with Heart Failure During the Coronavirus Disease 2019 Pandemic. ESC Heart Fail. 2020;7(6):4361-6. doi: 10.1002\/ehf2.13033.","journal-title":"ESC Heart Fail"},{"issue":"6","key":"key20231208082649_B25","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cardfail.2021.12.019","article-title":"The V-LAP System for Remote Left Atrial Pressure Monitoring of Patients with Heart Failure: Remote Left Atrial Pressure Monitoring","volume":"28","author":"Perl","year":"2022","unstructured":"25. Perl L, Meerkin D, D\u2018amario D, Avraham BB, Gal TB, Weitsman T, et al. The V-LAP System for Remote Left Atrial Pressure Monitoring of Patients with Heart Failure: Remote Left Atrial Pressure Monitoring. J Card Fail. 2022;28(6):963-72. doi: 10.1016\/j.cardfail.2021.12.019.","journal-title":"J Card Fail"},{"issue":"1","key":"key20231208082649_B26","doi-asserted-by":"crossref","first-page":"e21055","DOI":"10.2196\/21055","article-title":"Implantation of an Innovative Intracardiac Microcomputer System for Web-Based Real-Time Monitoring of Heart Failure: Usability and Patients\u2018 Attitudes","volume":"5","author":"Ancona","year":"2021","unstructured":"26. Ancona GD, Murero M, Feickert S, Kaplan H, \u00d6ner A, Ortak J, et al. Implantation of an Innovative Intracardiac Microcomputer System for Web-Based Real-Time Monitoring of Heart Failure: Usability and Patients\u2018 Attitudes. JMIR Cardio. 2021;5(1):e21055. doi: 10.2196\/21055.","journal-title":"JMIR Cardio"},{"issue":"18","key":"key20231208082649_B27","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1093\/eurheartj\/ehr050","article-title":"Sensitivity and Positive Predictive Value of Implantable Intrathoracic Impedance Monitoring as a Predictor of Heart Failure Hospitalizations: the SENSE-HF Trial","volume":"32","author":"Conraads","year":"2011","unstructured":"27. Conraads VM, Tavazzi L, Santini M, Oliva F, Gerritse B, Yu CM, et al. Sensitivity and Positive Predictive Value of Implantable Intrathoracic Impedance Monitoring as a Predictor of Heart Failure Hospitalizations: the SENSE-HF Trial. Eur Heart J. 2011;32(18):2266-73. doi: 10.1093\/eurheartj\/ehr050.","journal-title":"Eur Heart J"},{"issue":"8","key":"key20231208082649_B28","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.amjcard.2014.07.048","article-title":"Analysis of Different Device-Based Intrathoracic Impedance Vectors for Detection of Heart Failure Events (from the Detect Fluid Early from Intrathoracic Impedance Monitoring study)","volume":"114","author":"Heist","year":"2014","unstructured":"28. Heist EK, Herre JM, Binkley PF, Van Bakel AB, Porterfield JG, Porterfield LM, et al. Analysis of Different Device-Based Intrathoracic Impedance Vectors for Detection of Heart Failure Events (from the Detect Fluid Early from Intrathoracic Impedance Monitoring study). Am J Cardiol. 2014;114(8):1249-56. doi: 10.1016\/j.amjcard.2014.07.048.","journal-title":"Am J Cardiol"},{"issue":"3","key":"key20231208082649_B29","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ejhf.626","article-title":"Effects of Remote Monitoring on Clinical Outcomes and Use of Healthcare Resources in Heart Failure Patients with Biventricular Defibrillators: Results of the MORE-CARE Multicentre Randomized Controlled Trial","volume":"19","author":"Boriani","year":"2017","unstructured":"29. Boriani G, Costa A, Quesada A, Ricci RP, Favale S, Boscolo G, et al. Effects of Remote Monitoring on Clinical Outcomes and Use of Healthcare Resources in Heart Failure Patients with Biventricular Defibrillators: Results of the MORE-CARE Multicentre Randomized Controlled Trial. Eur J Heart Fail. 2017;19(3):416-25. doi: 10.1002\/ejhf.626.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"key20231208082649_B30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jchf.2016.12.011","article-title":"A Multisensor Algorithm Predicts Heart Failure Events in Patients with Implanted Devices: Results from the MultiSENSE Study","volume":"5","author":"Boehmer","year":"2017","unstructured":"30. Boehmer JP, Hariharan R, Devecchi FG, Smith AL, Molon G, Capucci A, et al. A Multisensor Algorithm Predicts Heart Failure Events in Patients with Implanted Devices: Results from the MultiSENSE Study. JACC Heart Fail. 2017;5(3):216-25. doi: 10.1016\/j.jchf.2016.12.011.","journal-title":"JACC Heart Fail"},{"issue":"14","key":"key20231208082649_B31","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.jaccas.2020.09.035","article-title":"Applications of the Multisensor HeartLogic Heart Failure Monitoring Algorithm During the COVID-19 Global Pandemic","volume":"2","author":"Egolum","year":"2020","unstructured":"31. Egolum UO, Parikh K, Lekavich C, Wosik J, Frazier-Mills C, Fudim M. Applications of the Multisensor HeartLogic Heart Failure Monitoring Algorithm During the COVID-19 Global Pandemic. JACC Case Rep. 2020;2(14):2265-9. doi: 10.1016\/j.jaccas.2020.09.035.","journal-title":"JACC Case Rep"},{"issue":"7","key":"key20231208082649_B32","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004669","article-title":"HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events: Results from the MultiSENSE Study","volume":"11","author":"Gardner","year":"2018","unstructured":"32. Gardner RS, Singh JP, Stancak B, Nair DG, Cao M, Schulze C, et al. HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events: Results from the MultiSENSE Study. Circ Heart Fail. 2018;11(7):e004669. doi: 10.1161\/CIRCHEARTFAILURE.117.004669.","journal-title":"Circ Heart Fail"},{"issue":"9","key":"key20231208082649_B33","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cardfail.2016.03.015","article-title":"Non-Invasive Lung IMPEDANCE-Guided Preemptive Treatment in Chronic Heart Failure Patients: a Randomized Controlled Trial (IMPEDANCE-HF Trial)","volume":"22","author":"Shochat","year":"2016","unstructured":"33. Shochat MK, Shotan A, Blondheim DS, Kazatsker M, Dahan I, Asif A, et al. Non-Invasive Lung IMPEDANCE-Guided Preemptive Treatment in Chronic Heart Failure Patients: a Randomized Controlled Trial (IMPEDANCE-HF Trial). J Card Fail. 2016;22(9):713-22. doi: 10.1016\/j.cardfail.2016.03.015.","journal-title":"J Card Fail"},{"issue":"7","key":"key20231208082649_B34","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2004.07.017","article-title":"Surgical Ventricular Restoration in the Treatment of Congestive Heart Failure Due to Post-Infarction Ventricular Dilation","volume":"44","author":"Athanasuleas","year":"2004","unstructured":"34. Athanasuleas CL, Buckberg GD, Stanley AW, Siler W, Dor V, Di Donato M, et al. Surgical Ventricular Restoration in the Treatment of Congestive Heart Failure Due to Post-Infarction Ventricular Dilation. J Am Coll Cardiol. 2004;44(7):1439-45. doi: 10.1016\/j.jacc.2004.07.017.","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"key20231208082649_B35","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa0900559","article-title":"Coronary Bypass Surgery with or without Surgical Ventricular Reconstruction","volume":"360","author":"Jones","year":"2009","unstructured":"35. Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O\u2018Connor CM, et al. Coronary Bypass Surgery with or without Surgical Ventricular Reconstruction. N Engl J Med. 2009;360(17):1705-17. doi: 10.1056\/NEJMoa0900559.","journal-title":"N Engl J Med"},{"issue":"1","key":"key20231208082649_B36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10741-011-9296-5","article-title":"Surgical Approaches to Left Ventricular Reconstruction: a Matter of Perspective","volume":"18","author":"Doenst","year":"2013","unstructured":"36. Doenst T. Surgical Approaches to Left Ventricular Reconstruction: a Matter of Perspective. Heart Fail Rev. 2013;18(1):15-25. doi: 10.1007\/s10741-011-9296-5.","journal-title":"Heart Fail Rev"},{"issue":"5","key":"key20231208082649_B37","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jtcvs.2012.09.007","article-title":"Insights from the STICH Trial: Change in Left Ventricular Size After Coronary Artery Bypass Grafting with and without Surgical Ventricular Reconstruction","volume":"146","author":"Michler","year":"2013","unstructured":"37. Michler RE, Rouleau JL, Al-Khalidi HR, Bonow RO, Pellikka PA, Pohost GM, et al. Insights from the STICH Trial: Change in Left Ventricular Size After Coronary Artery Bypass Grafting with and without Surgical Ventricular Reconstruction. J Thorac Cardiovasc Surg. 2013;146(5):1139-45.e6. doi: 10.1016\/j.jtcvs.2012.09.007.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"key20231208082649_B38","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ahj.2012.02.013","article-title":"Percutaneous Left Ventricular Partitioning in Patients with Chronic Heart Failure and a Prior Anterior Myocardial Infarction: Results of the PercutAneous Ventricular RestorAtion in Chronic Heart FailUre PaTiEnts Trial","volume":"163","author":"Mazzaferri","year":"2012","unstructured":"38. Mazzaferri EL Jr, Gradinac S, Sagic D, Otasevic P, Hasan AK, Goff TL, et al. Percutaneous Left Ventricular Partitioning in Patients with Chronic Heart Failure and a Prior Anterior Myocardial Infarction: Results of the PercutAneous Ventricular RestorAtion in Chronic Heart FailUre PaTiEnts Trial. Am Heart J. 2012;163(5):812-20.e1. doi: 10.1016\/j.ahj.2012.02.013.","journal-title":"Am Heart J"},{"issue":"6","key":"key20231208082649_B39","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4244\/EIJV11I6A143","article-title":"Percutaneous Ventricular Restoration (PVR) Therapy Using the Parachute Device in 100 Subjects with Ischaemic Dilated Heart Failure: One-Year Primary Endpoint Results of PARACHUTE III, a European trial","volume":"11","author":"Thomas","year":"2015","unstructured":"39. Thomas M, Nienaber CA, Ince H, Erglis A, Vukcevic V, Sch\u00e4fer U, et al. Percutaneous Ventricular Restoration (PVR) Therapy Using the Parachute Device in 100 Subjects with Ischaemic Dilated Heart Failure: One-Year Primary Endpoint Results of PARACHUTE III, a European trial. EuroIntervention. 2015;11(6):710-7. doi: 10.4244\/EIJV11I6A143.","journal-title":"EuroIntervention"},{"issue":"4","key":"key20231208082649_B40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ahj.2012.12.022","article-title":"The PARACHUTE IV Trial Design and Rationale: Percutaneous Ventricular Restoration Using the Parachute Device in Patients with Ischemic Heart Failure and Dilated Left Ventricles","volume":"165","author":"Costa","year":"2013","unstructured":"40. Costa MA, Pencina M, Nikolic S, Engels T, Templin B, Abraham WT. The PARACHUTE IV Trial Design and Rationale: Percutaneous Ventricular Restoration Using the Parachute Device in Patients with Ischemic Heart Failure and Dilated Left Ventricles. Am Heart J. 2013;165(4):531-6. doi: 10.1016\/j.ahj.2012.12.022.","journal-title":"Am Heart J"},{"issue":"6","key":"key20231208082649_B41","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s12265-021-10133-9","article-title":"Long-Term Results of Hybrid Left Ventricular Reconstruction in the Treatment of Ischemic Cardiomyopathy","volume":"14","author":"Naar","year":"2021","unstructured":"41. Naar J, Skalsk\u00fd I, Kr\u0171ger A, M\u00e1lek F, Van Bladel K, Annest LS, et al. Long-Term Results of Hybrid Left Ventricular Reconstruction in the Treatment of Ischemic Cardiomyopathy. J Cardiovasc Transl Res. 2021;14(6):1043-50. doi: 10.1007\/s12265-021-10133-9.","journal-title":"J Cardiovasc Transl Res"},{"issue":"3","key":"key20231208082649_B42","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cardfail.2014.01.005","article-title":"Effects of an Interatrial Shunt on Rest and Exercise Hemodynamics: Results of a Computer Simulation in Heart Failure","volume":"20","author":"Kaye","year":"2014","unstructured":"42. Kaye D, Shah SJ, Borlaug BA, Gustafsson F, Komtebedde J, Kubo S, et al. Effects of an Interatrial Shunt on Rest and Exercise Hemodynamics: Results of a Computer Simulation in Heart Failure. J Card Fail. 2014;20(3):212-21. doi: 10.1016\/j.cardfail.2014.01.005.","journal-title":"J Card Fail"},{"issue":"7","key":"key20231208082649_B43","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/ejhf.111","article-title":"Transcatheter Treatment of Heart Failure with Preserved or Mildly Reduced Ejection Fraction Using a Novel Interatrial Implant to Lower Left Atrial Pressure","volume":"16","author":"S\u00f8ndergaard","year":"2014","unstructured":"43. S\u00f8ndergaard L, Reddy V, Kaye D, Malek F, Walton A, Mates M, et al. Transcatheter Treatment of Heart Failure with Preserved or Mildly Reduced Ejection Fraction Using a Novel Interatrial Implant to Lower Left Atrial Pressure. Eur J Heart Fail. 2014;16(7):796-801. doi: 10.1002\/ejhf.111.","journal-title":"Eur J Heart Fail"},{"issue":"10025","key":"key20231208082649_B44","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0140-6736(16)00704-2","article-title":"A Transcatheter Intracardiac Shunt Device for Heart Failure with Preserved Ejection Fraction (REDUCE LAP-HF): a Multicentre, Open-Label, Single-Arm, Phase 1 Trial","volume":"387","author":"Hasenfu\u00df","year":"2016","unstructured":"44. Hasenfu\u00df G, Hayward C, Burkhoff D, Silvestry FE, McKenzie S, Gustafsson F, et al. A Transcatheter Intracardiac Shunt Device for Heart Failure with Preserved Ejection Fraction (REDUCE LAP-HF): a Multicentre, Open-Label, Single-Arm, Phase 1 Trial. Lancet. 2016;387(10025):1298-304. doi: 10.1016\/S0140-6736(16)00704-2.","journal-title":"Lancet"},{"issue":"12","key":"key20231208082649_B45","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003662","article-title":"One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure with Preserved Ejection Fraction","volume":"9","author":"Kaye","year":"2016","unstructured":"45. Kaye DM, Hasenfu\u00df G, Neuzil P, Post MC, Doughty R, Trochu JN, et al. One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure with Preserved Ejection Fraction. Circ Heart Fail. 2016;9(12):e003662. doi: 10.1161\/CIRCHEARTFAILURE.116.003662.","journal-title":"Circ Heart Fail"},{"issue":"4","key":"key20231208082649_B46","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.117.032094","article-title":"Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure with Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients with Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial","volume":"137","author":"Feldman","year":"2018","unstructured":"46. Feldman T, Mauri L, Kahwash R, Litwin S, Ricciardi MJ, van der Harst P, et al. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure with Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients with Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial. Circulation. 2018 Jan;137(4):364-75. doi: 10.1161\/CIRCULATIONAHA.117.032094.","journal-title":"Circulation"},{"issue":"10","key":"key20231208082649_B47","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/jamacardio.2018.2936","article-title":"One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure with Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients with Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial","volume":"3","author":"Shah","year":"2018","unstructured":"47. Shah SJ, Feldman T, Ricciardi MJ, Kahwash R, Lilly S, Litwin S, et al. One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure with Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients with Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial. JAMA Cardiol. 2018;3(10):968-77. doi: 10.1001\/jamacardio.2018.2936.","journal-title":"JAMA Cardiol"},{"issue":"10330","key":"key20231208082649_B48","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0140-6736(22)00016-2","article-title":"Atrial Shunt Device for Heart Failure with Preserved and Mildly Reduced Ejection Fraction (REDUCE LAP-HF II): a Randomised, Multicentre, Blinded, Sham-Controlled Trial","volume":"399","author":"Shah","year":"2022","unstructured":"48. Shah SJ, Borlaug BA, Chung ES, Cutlip DE, Debonnaire P, Fail PS, et al. Atrial Shunt Device for Heart Failure with Preserved and Mildly Reduced Ejection Fraction (REDUCE LAP-HF II): a Randomised, Multicentre, Blinded, Sham-Controlled Trial. Lancet. 2022;399(10330):1130-40. doi: 10.1016\/S0140-6736(22)00016-2.","journal-title":"Lancet"},{"issue":"9","key":"key20231208082649_B49","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.4244\/EIJY14M05_07","article-title":"Left Atrial Decompression Through Unidirectional Left-to-Right Interatrial Shunt for the Treatment of Left Heart Failure: First-in-Man Experience with the V-Wave Device","volume":"10","author":"Amat-Santos","year":"2015","unstructured":"49. Amat-Santos IJ, Bergeron S, Bernier M, Allende R, Ribeiro HB, Urena M, et al. Left Atrial Decompression Through Unidirectional Left-to-Right Interatrial Shunt for the Treatment of Left Heart Failure: First-in-Man Experience with the V-Wave Device. EuroIntervention. 2015;10(9):1127-31. doi: 10.4244\/EIJY14M05_07.","journal-title":"EuroIntervention"},{"key":"key20231208082649_B50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/24748706.2017.1326647","article-title":"Cardiac Unloading with an Implantable Interatrial Shunt in Heart Failure: Serial Observations in an Ovine Model of Ischemic Cardiomyopathy","volume":"1","author":"Eigler","year":"2017","unstructured":"50. Eigler NL, del Rio CL, Verheye S, McConnell PI, Lilly SM, George R, et al. Cardiac Unloading with an Implantable Interatrial Shunt in Heart Failure: Serial Observations in an Ovine Model of Ischemic Cardiomyopathy. Structural Heart. 2017;1(1\u20132):40-8. doi: 10.1080\/24748706.2017.1326647.","journal-title":"Structural Heart"},{"issue":"10025","key":"key20231208082649_B51","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(16)00585-7","article-title":"Unidirectional Left-to-Right Interatrial Shunting for Treatment of Patients with Heart Failure with Reduced Ejection Fraction: a Safety and Proof-of-Principle Cohort Study","volume":"387","author":"Del Trigo","year":"2016","unstructured":"51. Del Trigo M, Bergeron S, Bernier M, Amat-Santos IJ, Puri R, Campelo-Parada F, et al. Unidirectional Left-to-Right Interatrial Shunting for Treatment of Patients with Heart Failure with Reduced Ejection Fraction: a Safety and Proof-of-Principle Cohort Study. Lancet. 2016;387(10025):1290-7. doi: 10.1016\/S0140-6736(16)00585-7.","journal-title":"Lancet"},{"issue":"22","key":"key20231208082649_B52","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.jcin.2018.07.001","article-title":"Interatrial Shunting for Heart Failure: Early and Late Results from the First-in-Human Experience with the V-Wave System","volume":"11","author":"Rod\u00e9s-Cabau","year":"2018","unstructured":"52. Rod\u00e9s-Cabau J, Bernier M, Amat-Santos IJ, Ben Gal T, Nombela-Franco L, Del Blanco BG, et al. Interatrial Shunting for Heart Failure: Early and Late Results from the First-in-Human Experience with the V-Wave System. JACC Cardiovasc Interv. 2018;11(22):2300-10. doi: 10.1016\/j.jcin.2018.07.001.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"key20231208082649_B53","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4244\/EIJY15M07_08","article-title":"Implantable Atrial Flow Regulator for Severe, Irreversible Pulmonary Arterial Hypertension","volume":"11","author":"Patel","year":"2015","unstructured":"53. Patel MB, Samuel BP, Girgis RE, Parlmer MA, Vettukattil JJ. Implantable Atrial Flow Regulator for Severe, Irreversible Pulmonary Arterial Hypertension. EuroIntervention. 2015;11(6):706-9. doi: 10.4244\/EIJY15M07_08.","journal-title":"EuroIntervention"},{"issue":"5","key":"key20231208082649_B54","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4244\/EIJ-D-19-00342","article-title":"The AFR-PRELIEVE Trial: a Prospective, Non-Randomised, Pilot Study to Assess the Atrial Flow Regulator (AFR) in Heart Failure Patients with Either Preserved or Reduced Ejection Fraction","volume":"15","author":"Paitazoglou","year":"2019","unstructured":"54. Paitazoglou C, \u00d6zdemir R, Pfister R, Bergmann MW, Bartunek J, Kilic T, et al. The AFR-PRELIEVE Trial: a Prospective, Non-Randomised, Pilot Study to Assess the Atrial Flow Regulator (AFR) in Heart Failure Patients with Either Preserved or Reduced Ejection Fraction. EuroIntervention. 2019;15(5):403-10. doi: 10.4244\/EIJ-D-19-00342.","journal-title":"EuroIntervention"},{"issue":"5","key":"key20231208082649_B55","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/ejhf.2119","article-title":"One-Year Results of the First-in-Man Study Investigating the Atrial Flow Regulator for Left Atrial Shunting in Symptomatic Heart Failure Patients: the PRELIEVE Study","volume":"23","author":"Paitazoglou","year":"2021","unstructured":"55. Paitazoglou C, Bergmann MW, \u00d6zdemir R, Pfister R, Bartunek J, Kilic T, et al. One-Year Results of the First-in-Man Study Investigating the Atrial Flow Regulator for Left Atrial Shunting in Symptomatic Heart Failure Patients: the PRELIEVE Study. Eur J Heart Fail. 2021;23(5):800-10. doi: 10.1002\/ejhf.2119.","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"key20231208082649_B56","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jchf.2023.01.024","article-title":"No-Implant Interatrial Shunt for HFpEF: 6-Month Outcomes from Multicenter Pilot Feasibility Studies","volume":"11","author":"Udelson","year":"2023","unstructured":"56. Udelson JE, Barker CM, Wilkins G, Wilkins B, Gooley R, Lockwood S, et al. No-Implant Interatrial Shunt for HFpEF: 6-Month Outcomes from Multicenter Pilot Feasibility Studies. JACC Heart Fail. 2023;11(8 Pt 2):1121-30. doi: 10.1016\/j.jchf.2023.01.024.","journal-title":"JACC Heart Fail"},{"issue":"10","key":"key20231208082649_B57","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jcin.2020.02.022","article-title":"Percutaneous Atriotomy for Levoatrial-to-Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience","volume":"13","author":"Simard","year":"2020","unstructured":"57. Simard T, Labinaz M, Zahr F, Nazer B, Gray W, Hermiller J, et al. Percutaneous Atriotomy for Levoatrial-to-Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience. JACC Cardiovasc Interv. 2020;13(10):1236-47. doi: 10.1016\/j.jcin.2020.02.022.","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"key20231208082649_B58","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/CIRCULATIONAHA.107.760405","article-title":"Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy","volume":"118","author":"Olshansky","year":"2008","unstructured":"58. Olshansky B, Sabbah HN, Hauptman PJ, Colucci WS. Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy. Circulation. 2008;118(8):863-71. doi: 10.1161\/CIRCULATIONAHA.107.760405.","journal-title":"Circulation"},{"issue":"5","key":"key20231208082649_B59","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.RES.68.5.1471","article-title":"Vagal Stimulation and Prevention of Sudden Death in Conscious Dogs with a Healed Myocardial Infarction","volume":"68","author":"Vanoli","year":"1991","unstructured":"59. Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ. Vagal Stimulation and Prevention of Sudden Death in Conscious Dogs with a Healed Myocardial Infarction. Circ Res. 1991;68(5):1471-81. doi: 10.1161\/01.res.68.5.1471.","journal-title":"Circ Res"},{"issue":"9","key":"key20231208082649_B60","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.ejheart.2008.07.016","article-title":"Long Term Vagal Stimulation in Patients with Advanced Heart Failure: First Experience in Man","volume":"10","author":"Schwartz","year":"2008","unstructured":"60. Schwartz PJ, De Ferrari GM, Sanzo A, Landolina M, Rordorf R, Raineri C, et al. Long Term Vagal Stimulation in Patients with Advanced Heart Failure: First Experience in Man. Eur J Heart Fail. 2008;10(9):884-91. doi: 10.1016\/j.ejheart.2008.07.016.","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"key20231208082649_B61","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurheartj\/ehq391","article-title":"Chronic Vagus Nerve Stimulation: a New and Promising Therapeutic Approach for Chronic Heart Failure","volume":"32","author":"Ferrari","year":"2011","unstructured":"61. De Ferrari GM, Crijns HJ, Borggrefe M, Milasinovic G, Smid J, Zabel M, et al. Chronic Vagus Nerve Stimulation: a New and Promising Therapeutic Approach for Chronic Heart Failure. Eur Heart J. 2011;32(7):847-55. doi: 10.1093\/eurheartj\/ehq391.","journal-title":"Eur Heart J"},{"issue":"2","key":"key20231208082649_B62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jacc.2016.03.525","article-title":"Vagus Nerve Stimulation for the Treatment of Heart Failure: the INOVATE-HF Trial","volume":"68","author":"Gold","year":"2016","unstructured":"62. Gold MR, Van Veldhuisen DJ, Hauptman PJ, Borggrefe M, Kubo SH, Lieberman RA, et al. Vagus Nerve Stimulation for the Treatment of Heart Failure: the INOVATE-HF Trial. J Am Coll Cardiol. 2016;68(2):149-58. doi: 10.1016\/j.jacc.2016.03.525.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"key20231208082649_B63","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.cardfail.2014.08.009","article-title":"Autonomic Regulation Therapy Via Left or Right Cervical Vagus Nerve Stimulation in Patients with Chronic Heart Failure: Results of the ANTHEM-HF Trial","volume":"20","author":"Premchand","year":"2014","unstructured":"63. Premchand RK, Sharma K, Mittal S, Monteiro R, Dixit S, Libbus I, et al. Autonomic Regulation Therapy Via Left or Right Cervical Vagus Nerve Stimulation in Patients with Chronic Heart Failure: Results of the ANTHEM-HF Trial. J Card Fail. 2014;20(11):808-16. doi: 10.1016\/j.cardfail.2014.08.009.","journal-title":"J Card Fail"},{"key":"key20231208082649_B64","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2020.09.072","article-title":"Long-Term Follow-Up of Patients with Heart Failure and Reduced Ejection Fraction Receiving Autonomic Regulation Therapy in the ANTHEM-HF Pilot Study","volume":"323","author":"Sharma","year":"2021","unstructured":"64. Sharma K, Premchand RK, Mittal S, Monteiro R, Libbus I, DiCarlo LA, et al. Long-Term Follow-Up of Patients with Heart Failure and Reduced Ejection Fraction Receiving Autonomic Regulation Therapy in the ANTHEM-HF Pilot Study. Int J Cardiol. 2021;323:175-8. doi: 10.1016\/j.ijcard.2020.09.072.","journal-title":"Int J Cardiol"},{"issue":"7","key":"key20231208082649_B65","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/eurheartj\/ehu345","article-title":"Chronic Vagal Stimulation for the Treatment of Low Ejection Fraction Heart Failure: Results of the NEural Cardiac Therapy For Heart Failure (NECTAR-HF) Randomized Controlled Trial","volume":"36","author":"Zannad","year":"2015","unstructured":"65. Zannad F, De Ferrari GM, Tuinenburg AE, Wright D, Brugada J, Butter C, et al. Chronic Vagal Stimulation for the Treatment of Low Ejection Fraction Heart Failure: Results of the NEural Cardiac Therapy For Heart Failure (NECTAR-HF) Randomized Controlled Trial. Eur Heart J. 2015;36(7):425-33. doi: 10.1093\/eurheartj\/ehu345.","journal-title":"Eur Heart J"},{"key":"key20231208082649_B66","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijcard.2017.06.036","article-title":"Long-Term Vagal Stimulation for Heart Failure: Eighteen Month Results from the NEural Cardiac Therapy for Heart Failure (NECTAR-HF) Trial","volume":"244","author":"De Ferrari","year":"2017","unstructured":"66. De Ferrari GM, Stolen C, Tuinenburg AE, Wright DJ, Brugada J, Butter C, et al. Long-Term Vagal Stimulation for Heart Failure: Eighteen Month Results from the NEural Cardiac Therapy for Heart Failure (NECTAR-HF) Trial. Int J Cardiol. 2017;244:229-34. doi: 10.1016\/j.ijcard.2017.06.036.","journal-title":"Int J Cardiol"},{"issue":"1","key":"key20231208082649_B67","first-page":"75","article-title":"Comparison of Symptomatic and Functional Responses to Vagus Nerve Stimulation in ANTHEM-HF, INOVATE-HF, and NECTAR-HF","volume":"7","author":"Anand","year":"2020","unstructured":"67. Anand IS, Konstam MA, Klein HU, Mann DL, Ardell JL, Gregory DD, et al. Comparison of Symptomatic and Functional Responses to Vagus Nerve Stimulation in ANTHEM-HF, INOVATE-HF, and NECTAR-HF. ESC Heart Fail. 2020;7(1):75-83. doi: 10.1002\/ehf2.12592.","journal-title":"ESC Heart Fail"},{"issue":"11","key":"key20231208082649_B68","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.005879","article-title":"Impact of Autonomic Regulation Therapy in Patients with Heart Failure: ANTHEM-HFrEF Pivotal Study Design","volume":"12","author":"Konstam","year":"2019","unstructured":"68. Konstam MA, Udelson JE, Butler J, Klein HU, Parker JD, Teerlink JR, et al. Impact of Autonomic Regulation Therapy in Patients with Heart Failure: ANTHEM-HFrEF Pivotal Study Design. Circ Heart Fail. 2019;12(11):e005879. doi: 10.1161\/CIRCHEARTFAILURE.119.005879.","journal-title":"Circ Heart Fail"},{"issue":"6","key":"key20231208082649_B69","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jchf.2015.02.006","article-title":"Baroreflex Activation Therapy for the Treatment of Heart Failure with a Reduced Ejection Fraction","volume":"3","author":"Abraham","year":"2015","unstructured":"69. Abraham WT, Zile MR, Weaver FA, Butter C, Ducharme A, Halbach M, et al. Baroreflex Activation Therapy for the Treatment of Heart Failure with a Reduced Ejection Fraction. JACC Heart Fail. 2015;3(6):487-96. doi: 10.1016\/j.jchf.2015.02.006.","journal-title":"JACC Heart Fail"},{"issue":"2","key":"key20231208082649_B70","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.semtcvs.2016.04.017","article-title":"Surgical Experience and Long-Term Results of Baroreflex Activation Therapy for Heart Failure with Reduced Ejection Fraction","volume":"28","author":"Weaver","year":"2016","unstructured":"70. Weaver FA, Abraham WT, Little WC, Butter C, Ducharme A, Halbach M, et al. Surgical Experience and Long-Term Results of Baroreflex Activation Therapy for Heart Failure with Reduced Ejection Fraction. Semin Thorac Cardiovasc Surg. 2016;28(2):320-8. doi: 10.1053\/j.semtcvs.2016.04.017.","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"10","key":"key20231208082649_B71","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/ejhf.299","article-title":"Baroreflex Activation Therapy for the Treatment of Heart Failure with a Reduced Ejection Fraction: Safety and Efficacy in Patients with and without Cardiac Resynchronization Therapy","volume":"17","author":"Zile","year":"2015","unstructured":"71. Zile MR, Abraham WT, Weaver FA, Butter C, Ducharme A, Halbach M, et al. Baroreflex Activation Therapy for the Treatment of Heart Failure with a Reduced Ejection Fraction: Safety and Efficacy in Patients with and without Cardiac Resynchronization Therapy. Eur J Heart Fail. 2015;17(10):1066-74. doi: 10.1002\/ejhf.299.","journal-title":"Eur J Heart Fail"},{"key":"key20231208082649_B72","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijcard.2018.04.075","article-title":"Baroreflex Activation Therapy for the Treatment of Heart Failure with Reduced Ejection Fraction in Patients with and without Coronary Artery Disease","volume":"266","author":"Halbach","year":"2018","unstructured":"72. Halbach M, Abraham WT, Butter C, Ducharme A, Klug D, Little WC, et al. Baroreflex Activation Therapy for the Treatment of Heart Failure with Reduced Ejection Fraction in Patients with and without Coronary Artery Disease. Int J Cardiol. 2018;266:187-92. doi: 10.1016\/j.ijcard.2018.04.075.","journal-title":"Int J Cardiol"},{"issue":"1","key":"key20231208082649_B73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2020.05.015","article-title":"Baroreflex Activation Therapy in Patients with Heart Failure with Reduced Ejection Fraction","volume":"76","author":"Zile","year":"2020","unstructured":"73. Zile MR, Lindenfeld J, Weaver FA, Zannad F, Galle E, Rogers T, et al. Baroreflex Activation Therapy in Patients with Heart Failure with Reduced Ejection Fraction. J Am Coll Cardiol. 2020;76(1):1-13. doi: 10.1016\/j.jacc.2020.05.015.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"key20231208082649_B74","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ehf2.14136","article-title":"Aortic Thoracic Neuromodulation in Heart Failure with Preserved Ejection Fraction","volume":"10","author":"Paolisso","year":"2023","unstructured":"74. Paolisso P, Dagan A, Gallinoro E, De Colle C, Bertolone DT, Moya A, et al. Aortic Thoracic Neuromodulation in Heart Failure with Preserved Ejection Fraction. ESC Heart Fail. 2023;10(1):699-704. doi: 10.1002\/ehf2.14136.","journal-title":"ESC Heart Fail"},{"issue":"3","key":"key20231208082649_B75","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008301","article-title":"Renal Denervation for Patients with Heart Failure: Making a Full Circle","volume":"14","author":"Fudim","year":"2021","unstructured":"75. Fudim M, Sobotka PA, Piccini JP, Patel MR. Renal Denervation for Patients with Heart Failure: Making a Full Circle. Circ Heart Fail. 2021;14(3):e008301. doi: 10.1161\/CIRCHEARTFAILURE.121.008301.","journal-title":"Circ Heart Fail"},{"issue":"10234","key":"key20231208082649_B76","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0140-6736(20)30554-7","article-title":"Efficacy of Catheter-Based Renal Denervation in the Absence of Antihypertensive Medications (SPYRAL HTN-OFF MED Pivotal): a Multicentre, Randomised, Sham-Controlled Trial","volume":"395","author":"B\u00f6hm","year":"2020","unstructured":"76. B\u00f6hm M, Kario K, Kandzari DE, Mahfoud F, Weber MA, Schmieder RE, et al. Efficacy of Catheter-Based Renal Denervation in the Absence of Antihypertensive Medications (SPYRAL HTN-OFF MED Pivotal): a Multicentre, Randomised, Sham-Controlled Trial. Lancet. 2020;395(10234):1444-51. doi: 10.1016\/S0140-6736(20)30554-7.","journal-title":"Lancet"},{"key":"key20231208082649_B77","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-physiol-031620-093431","article-title":"Renal Denervation to Treat Heart Failure","volume":"83","author":"Lefer","year":"2021","unstructured":"77. Lefer DJ. Renal Denervation to Treat Heart Failure. Annu Rev Physiol. 2021;83:39-58. doi: 10.1146\/annurev-physiol-031620-093431.","journal-title":"Annu Rev Physiol"},{"issue":"3","key":"key20231208082649_B78","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2012.09.019","article-title":"First-in-Man Safety Evaluation of Renal Denervation for Chronic Systolic Heart Failure: Primary Outcome from REACH-Pilot Study","volume":"162","author":"Davies","year":"2013","unstructured":"78. Davies JE, Manisty CH, Petraco R, Barron AJ, Unsworth B, Mayet J, et al. First-in-Man Safety Evaluation of Renal Denervation for Chronic Systolic Heart Failure: Primary Outcome from REACH-Pilot Study. Int J Cardiol. 2013;162(3):189-92. doi: 10.1016\/j.ijcard.2012.09.019.","journal-title":"Int J Cardiol"},{"issue":"9","key":"key20231208082649_B79","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cardfail.2017.06.004","article-title":"Sympathetic Response and Outcomes Following Renal Denervation in Patients with Chronic Heart Failure: 12-Month Outcomes from the Symplicity HF Feasibility Study","volume":"23","author":"Hopper","year":"2017","unstructured":"79. Hopper I, Gronda E, Hoppe UC, Rundqvist B, Marwick TH, Shetty S, et al. Sympathetic Response and Outcomes Following Renal Denervation in Patients with Chronic Heart Failure: 12-Month Outcomes from the Symplicity HF Feasibility Study. J Card Fail. 2017;23(9):702-7. doi: 10.1016\/j.cardfail.2017.06.004.","journal-title":"J Card Fail"},{"issue":"4","key":"key20231208082649_B80","doi-asserted-by":"crossref","first-page":"E153","DOI":"10.1002\/ccd.26475","article-title":"Preliminary Effects of Renal Denervation with Saline Irrigated Catheter on Cardiac Systolic Function in Patients with Heart Failure: a Prospective, Randomized, Controlled, Pilot Study","volume":"89","author":"Chen","year":"2017","unstructured":"80. Chen W, Ling Z, Xu Y, Liu Z, Su L, Du H, et al. Preliminary Effects of Renal Denervation with Saline Irrigated Catheter on Cardiac Systolic Function in Patients with Heart Failure: a Prospective, Randomized, Controlled, Pilot Study. Catheter Cardiovasc Interv. 2017;89(4):E153-61. doi: 10.1002\/ccd.26475.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"key20231208082649_B81","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10286-020-00716-y","article-title":"Efficacy and Safety of Catheter-Based Renal Denervation for Heart Failure with Reduced Ejection Fraction: a Systematic Review and Meta-Analysis","volume":"30","author":"Lian","year":"2020","unstructured":"81. Lian Z, Yu SR, Song JX, Lee CY, Li SF, Cui YX, et al. Efficacy and Safety of Catheter-Based Renal Denervation for Heart Failure with Reduced Ejection Fraction: a Systematic Review and Meta-Analysis. Clin Auton Res. 2020;30(6):521-30. doi: 10.1007\/s10286-020-00716-y.","journal-title":"Clin Auton Res"},{"issue":"4","key":"key20231208082649_B82","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/ccd.28393","article-title":"Renal Denervation in Patients with Heart Failure Secondary to Chagas\u2018 Disease: a Pilot Randomized Controlled Trial","volume":"94","author":"Spadaro","year":"2019","unstructured":"82. Spadaro AG, Bocchi EA, Souza GE, Antonio E Filho, Mariani J Jr, Campos CM, et al. Renal Denervation in Patients with Heart Failure Secondary to Chagas\u2018 Disease: a Pilot Randomized Controlled Trial. Catheter Cardiovasc Interv. 2019;94(4):644-50. doi: 10.1002\/ccd.28393.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"key20231208082649_B83","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12471-021-01633-z","article-title":"Endovascular Renal Sympathetic Denervation to Improve Heart Failure with Reduced Ejection Fraction: the IMPROVE-HF-I Study","volume":"30","author":"Feyz","year":"2022","unstructured":"83. Feyz L, Panday RN, Henneman M, Verzijlbergen F, Constantinescu AA, van Dalen BM, et al. Endovascular Renal Sympathetic Denervation to Improve Heart Failure with Reduced Ejection Fraction: the IMPROVE-HF-I Study. Neth Heart J. 2022;30(3):149-59. doi: 10.1007\/s12471-021-01633-z.","journal-title":"Neth Heart J"},{"issue":"3","key":"key20231208082649_B84","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007421","article-title":"Renal Sympathetic Denervation in Patients with Heart Failure with Preserved Ejection Fraction","volume":"14","author":"Kresoja","year":"2021","unstructured":"84. Kresoja KP, Rommel KP, Fengler K, von Roeder M, Besler C, L\u00fccke C, et al. Renal Sympathetic Denervation in Patients with Heart Failure with Preserved Ejection Fraction. Circ Heart Fail. 2021;14(3):e007421. doi: 10.1161\/CIRCHEARTFAILURE.120.007421.","journal-title":"Circ Heart Fail"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/abccardiol.org\/article\/estrategias-percutaneas-em-doencas-estruturais-foco-em-insuficiencia-cardiaca-cronica\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:14:41Z","timestamp":1747401281000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/estrategias-percutaneas-em-doencas-estruturais-foco-em-insuficiencia-cardiaca-cronica\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":84,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,12,7]]}},"alternative-id":["10.36660\/abc.20220496"],"URL":"https:\/\/doi.org\/10.36660\/abc.20220496","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"type":"print","value":"0066-782X"},{"type":"electronic","value":"1678-4170"}],"subject":[],"published":{"date-parts":[[2023,11]]},"article-number":"e20220496"}}